Aspirin for myocardial infarction. Clinical pharmacokinetic considerations.
Bochner
F
F
Department of Clinical and Experimental Pharmacology, University of Adelaide, Australia.
Lloyd
J V
JV
D001241:Aspirin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin